O=c1[nH]c2cc([N+](=O)[O-])c(N/N=C/c3ccc([N+](=O)[O-])o3)c([N+](=O)[O-])c2[nH]1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?